Clinical evaluation of a new prostaglandin analog in pigs: 2. Prophylaxis and therapy of anestrus after weaning in sows and first litter gilts.
Alfaprostol, a new prostaglandin F2alpha (PGF) analog was given in a first trial at two dose levels known to be luteolytic (1 and 2 mg) to 200 sows and first litter gilts at the day of weaning after a 21-day lactation period; 189 controls received saline only. The treatment with alfaprostol shortened the interval to heat (6.0 vs 11.3 days; p<0.01) and increased the percentage of animals coming into heat within 10 days (84.0 vs 65.5%; p<0.01). Fertility to a.i. and litter size at the subsequent parturition were normal. In a second trial, 100 first litter gilts and 100 sows received alfaprostol, 1 or 2 mg, respectively, during July and August when high environmental temperatures tend to increase the rate of anestrus. Again, treatment with alfaprostol shortened effectively the interval to heat (5.9 vs 17.4 days in gilts, p<0.001; 5.6 vs 9.7 days in sows; p<0.01) and greatly increased the number of animals in heat (81 vs 47% in gilts, 83 vs 62% in sows; p<0.001). The effect on the seasonal incidence of clinical anestrus was marked; it was more pronounced in gilts than in sows, expressed by the length of time it took to resume cyclic functions and the lower percentage of animals coming into heat (p<0.001). The effect of alfaprostol was equally well expressed in first litter gilts and sows. In a third trial, 295 anestrous sows and gilts were treated on day 22 after weaning with either 2 mg alfaprostol, or 400 I.U. PMSG+200 I.U. hCG, or saline. Within five days after weaning, 38% of the alfaprostol treated, and 78% and 23% of the animals treated with PMSG/hCG and saline came into heat.
Jöchle
W
W
Cerne
F
F